Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D006801:Humans; D007167:Immunotherapy; D007939:Leukemia L1210 / Q000628:therapy*; D007942:Leukemia, Experimental / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy*; D051379:Mice; D011925:Rauscher Virus
D000970:Antineoplastic Agents; D001500:BCG Vaccine